FAMDX | VEXRX | FAMDX / VEXRX | |
Total Expense Ratio | 1.14 | 0.33 | 345% |
Annual Report Gross Expense Ratio | 1.14 | 0.33 | 345% |
Fund Existence | 10 years | 24 years | - |
Gain YTD | -1.752 | -0.225 | 780% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 50000 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 421M | 20.1B | 2% |
Annual Yield % from dividends | 0.00 | 0.52 | - |
Returns for 1 year | 3.09 | -1.64 | -189% |
Returns for 3 years | 22.04 | 20.18 | 109% |
Returns for 5 years | 65.47 | 11.81 | 555% |
Returns for 10 years | N/A | 15.36 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 16.26 | 0.53 | +3.37% |
ProShares UltraShort Nasdaq Biotech | |||
FAPR | 42.37 | N/A | N/A |
FT Vest US Equity Buffer ETF Apr | |||
DFAC | 36.38 | -0.23 | -0.63% |
Dimensional US Core Equity 2 ETF | |||
GINN | 67.45 | -0.68 | -1.00% |
Goldman Sachs Innovate Equity ETF | |||
FLSW | 37.87 | -0.55 | -1.42% |
Franklin FTSE Switzerland ETF |